Comparing Pericapsular Nerve Group Block With Lumbar Erector Spinae Plain Block in Total Hip Arthroplasty Surgery

Postoperative Pain Clinical Trial

Official title:

Comparing Postoperative Opioid Consumption of Pericapsular Nerve Group (PENG) Block With Lumbar Erector Spinae Plain Block in Total Hip Arthroplasty Surgery

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06059339
• Other study ID #: 01.2023.886
• Status: Active, not recruiting
• Phase: N/A
• Start date: July 22, 2022
• Est. completion date: May 22, 2024

Study information

• Verified date: April 2024
• Source: Marmara University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Total hip arthroplasty is a common surgical procedure aiming to improve mobility and quality of life in patients suffering from hip pain. Despite being a frequently performed procedure, there is high variability in the peri-operative anaesthetic and analgesic management for total hip arthroplasty. Beyond the immediate postoperative period, regional anesthesia and analgesia can have potentially beneficial effects on long-term outcomes, especially on postoperative pain, functional rehabilitation and morbidity . The primary implication of this study is to compare postoperative opioid consumption of patients' after total hip arthroplasty using pericapsular nerve group (PENG) block with lumbar erector spinae plain block.

Description:

Total hip arthroplasty is a common surgical procedure aiming to improve mobility and quality of life in patients suffering from hip pain. Despite being a frequently performed procedure, there is high variability in the peri-operative anaesthetic and analgesic management for total hip arthroplasty. Beyond the immediate postoperative period, regional anesthesia and analgesia can have potentially beneficial effects on long-term outcomes, especially on postoperative pain, functional rehabilitation and morbidity . The primary implication of this study is to compare postoperative opioid consumption of patients' after total hip arthroplasty using pericapsular nerve group (PENG) block with lumbar erector spinae plain block.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 66
• Est. completion date: May 22, 2024
• Est. primary completion date: April 22, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Patients over 18 years old, undergoing total hip arthroplasty surgery

Exclusion Criteria:

• Patients with solid organ dysfunction, chronic opioid or corticosteroid use, bleeding diathesis, patients receiving inpatient medication, patients with psychiatric disorders and patients who cannot be contacted after surgery.

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain
• Total Hip Arthroplasty

Intervention

Other:
• Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups
Procedure/Surgery: Regional Block Comparison Comparing postoperative pain and opioid consumption in groups

Locations

Country	Name	City	State
Turkey	Marmara University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Marmara University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative Pain Scores	Comparing pain scores with Numeric Rating Scale (NRS)	48 Hours
Primary	Opioid Consumption	Comparing opioid consumption via Patient Controlled Analgesia (PCA) device	48 Hours
Secondary	Patient Satisfaction	Patient Satisfaction score- 0 to 5: unsatisfied:0 satisfied:5	48 Hours
Secondary	Complications Related to Pain Management	Complications Related to Pain Management- nausea, vomiting, itching	48 Hours
Secondary	Time of Mobilization	the time between the surgery to mobilization of the patient	7 Days